Patents by Inventor Petra Loos

Petra Loos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20230181739
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: November 11, 2022
    Publication date: June 15, 2023
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20220040267
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: July 3, 2021
    Publication date: February 10, 2022
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART
    Publication number: 20220023392
    Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed.
    Type: Application
    Filed: July 3, 2021
    Publication date: January 27, 2022
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20200297852
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: February 26, 2020
    Publication date: September 24, 2020
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 10610595
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: April 7, 2020
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20180125945
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: October 10, 2017
    Publication date: May 10, 2018
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20180125981
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: October 13, 2017
    Publication date: May 10, 2018
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART
    Publication number: 20180125944
    Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed.
    Type: Application
    Filed: October 6, 2017
    Publication date: May 10, 2018
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 9895424
    Abstract: Stabilized pharmaceutical formulations of insulin analogs and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: February 20, 2018
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin aspart
    Patent number: 9895423
    Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: February 20, 2018
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stable Formulation of Insulin Glulisine
    Publication number: 20180036411
    Abstract: An aqueous pharmaceutical formulation comprising 200-1000 U/mL of insulin glulisine.
    Type: Application
    Filed: October 27, 2017
    Publication date: February 8, 2018
    Inventors: Petra Loos, Thomas Gehrmann, Harald Berchtold, Ulrich Werner, Matthias Ganz
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 9839692
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: December 12, 2017
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 9839675
    Abstract: Stabilized pharmaceutical formulations of insulin analogs and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: December 12, 2017
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives
    Publication number: 20150216941
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: January 8, 2015
    Publication date: August 6, 2015
    Applicant: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives
    Publication number: 20150216981
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: January 8, 2015
    Publication date: August 6, 2015
    Applicant: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART
    Publication number: 20150190475
    Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed.
    Type: Application
    Filed: January 8, 2015
    Publication date: July 9, 2015
    Applicant: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stable Formulation of Insulin Glulisine
    Publication number: 20150119323
    Abstract: An aqueous pharmaceutical formulation comprising 200-1000 U/mL of insulin glulisine.
    Type: Application
    Filed: October 24, 2014
    Publication date: April 30, 2015
    Inventors: Petra Loos, Thomas Gehrmann, Harald Berchtold, Ulrich Werner, Matthias Ganz
  • LONG-ACTING INSULIN FORMULATIONS
    Publication number: 20140206611
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: March 20, 2014
    Publication date: July 24, 2014
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fuerst, Werner Mueller, Katrin Teresch, Ulrich Werner, Petra Loos, Isabell Schoettle
  • LONG-ACTING FORMULATIONS OF INSULINS
    Publication number: 20120122774
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: December 2, 2011
    Publication date: May 17, 2012
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fürst, Werner Müller, Katrin Tertsch, Ulrich Werner, Petra Loos, Isabell Schöttle
  • LONG-ACTING FORMULATIONS OF INSULINS
    Publication number: 20110301081
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: May 18, 2011
    Publication date: December 8, 2011
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fürst, Werner Müller, Katrin Tertsch, Ulrich Werner, Petra Loos, Isabell Schöttle